PharmacoEpidemiology and Drug Safety (PharmaSafe)
Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety Research Group (PharmaSafe) covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.
The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, biostatistics, health economics and pharmacotherapy.
New article on the use and validity of child neurodevelopment outcome measures
July 12, 2019 7:24 PM
See a video abstract of the recently published systematic review on the use and validity of child neurodevelopent outcome measures in studies on prenatal exposure to psychotropic and analgesic medications.
New article on prenatal exposure to benzodiazepines and z-hypnotics
July 4, 2019 3:35 PM
New article by PharmaSafe researchers on the impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age.
European mega-venture for safe medications during pregnancy
June 11, 2019 2:36 PM
Professor Hedvig Nordeng is one of the researchers involved in the new and massive European research project ConcePTION, where the aim is to generate the knowledge that pregnant women want – and need – about the safety of medications.
PharmaSafe at the NFIF conference 2019
June 4, 2019 10:10 AM
PharmaSafe researchers had several contributions to NFIF's annual conference.
New PharmaSafe article
Apr. 30, 2019 10:47 AM
Master's students are important for our research group!